The Effects of Long-acting Methylphenidate on Academic Activity and Related Constructs in Children With ADHD
NCT02501798 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 61
Last updated 2016-05-13
Summary
This study aims at investigating the direct effects of methylphenidate on school performance of primary school children. Although behavioral effects of this frequently prescribed drug are thoroughly studied (and confirmed), the effects of methylphenidate on school performance are less clear. Recent overviews indicate that effects are mainly quantitative and subject-specific. To gain more insight in this issue, the current double blind placebo controlled crossover study investigates not only the effects of methylphenidate on school performance but also it's effect on related variables such as short term memory, motivation and behavior. 60 children with ADHD are included and tested twice (with medication and with placebo) at their primary school.
Conditions
- Attention Deficit Hyperactivity Disorder
Interventions
- DRUG
-
Methylphenidate
Drug: Methylphenidate
- DRUG
-
Drug: Placebo
Sponsors & Collaborators
-
Shire
collaborator INDUSTRY -
VU University of Amsterdam
lead OTHER
Principal Investigators
-
Jaap Oosterlaan, Prof. Dr. · VU University of Amsterdam
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 8 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2015-07-31
- Completion
- 2016-05-31
Countries
- Netherlands
Study Locations
More Related Trials
-
The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom Setting
NCT00381758 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder.
NCT00246220 ·Status: COMPLETED ·Phase: PHASE3
-
A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)
NCT00500149 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)
NCT00428792 ·Status: COMPLETED ·Phase: PHASE3
-
Stimulant Effects on Brain Activity
NCT02453698 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD)
NCT01259492 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing the Efficacy of Methylphenidate, Dextroamphetamine and Placebo in Children Diagnosed With ADHD
NCT01220440 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors
NCT01624649 ·Status: COMPLETED
-
Effects of Evening Dose of Immediate Release Methylphenidate on Sleep in Children With ADHD
NCT02638168 ·Status: TERMINATED ·Phase: PHASE4
-
Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder
NCT02951754 ·Status: RECRUITING ·Phase: PHASE4
-
Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD
NCT00466791 ·Status: COMPLETED ·Phase: PHASE2
-
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
NCT00178503 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effects of a Single Dose of Methylphenidate on Motor Performance
NCT04283604 ·Status: RECRUITING ·Phase: PHASE4
-
Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder
NCT02247986 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD
NCT00619840 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT00409708 ·Status: COMPLETED ·Phase: PHASE2
-
Methylphenidate in KBG Syndrome: N-of-1 Series
NCT06465641 ·Status: RECRUITING ·Phase: PHASE4
-
Motivated Behavior in Adults With and Without ADHD
NCT02630017 ·Status: COMPLETED ·Phase: PHASE2
-
Stimulant Drug Treatment of Attention-Deficit Hyperactivity Disorder (AD/HD), Inattentive Type
NCT00824317 ·Status: COMPLETED ·Phase: NA
-
Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders
NCT00025779 ·Status: COMPLETED ·Phase: NA
-
The Effect of Methylphenidate Versus Placebo on State Anxiety in Children With Attention Deficit Hyperactivity Disorder.
NCT01798459 ·Status: UNKNOWN ·Phase: NA
-
Methylphenidate Study in Young Children With Developmental Disorders
NCT00517504 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)
NCT01554046 ·Status: COMPLETED ·Phase: NA
-
Enhancing ADHD Driving Performance With Stimulant Medication
NCT00572026 ·Status: UNKNOWN ·Phase: NA
-
Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT03327402 ·Status: COMPLETED ·Phase: PHASE1